Lifeward (LFWD) PE Ratio: History & Chart

Basis: FMP quote price / unrounded diluted EPS from four consecutive issuer fiscal quarters. Source: stored company filings and market data; unavailable inputs remain N/A.

The P/E ratio is N/A as of 2026-10-06T17:07:45.669Z.

Stored calculation inputs

Calculation as of: 2026-10-06T17:07:45.669Z.

Quote observation: 2026-10-06T17:05:19.000Z. Amounts in USD. The price header may show a later quote.

Quote price: 6.6
Unrounded diluted TTM EPS · period ending 2026-06-30: -16.82

FMP input reference: f6adff8253f4c85dc5eb0f5c76b7f284768243a99251a0912c87940a98678e1d

Forward PE Ratio|PEG Ratio|P/B Ratio|EPS|All Metrics

LFWD PE Ratio Metrics

PE RATIO

N/A

LFWD Competitors' PE Ratio

LFWD

Lifeward Ltd.

Current

Market Cap

$10.63M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

LSTA

Lisata Therapeutics, Inc.

vs LFWD

Market Cap

$10.65M

PE Ratio

N/A

TTM Avg

2.09

3Y Avg

2.09

5Y Avg

2.09

GDTC

CytoMed Therapeutics Limited

vs LFWD

Market Cap

$10.51M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

MSLE

Satellos Bioscience Inc.

vs LFWD

Market Cap

$10.44M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

CNSY

Cerenome, Inc.

vs LFWD

Market Cap

$11.01M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

PLRZ

Polyrizon Ltd.

vs LFWD

Market Cap

$10.34M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

SNTI

Senti Biosciences, Inc.

vs LFWD

Market Cap

$10.33M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

CABR

Caring Brands, Inc.

vs LFWD

Market Cap

$10.84M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

PLUR

Pluri Inc.

vs LFWD

Market Cap

$11.11M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

KPRX

Kiora Pharmaceuticals, Inc.

vs LFWD

Market Cap

$11.12M

PE Ratio

N/A

TTM Avg

2.43

3Y Avg

2.43

5Y Avg

2.43

NAME	MARKET CAP	PE RATIO	TTM	3Y	5Y
Lifeward Ltd. (LFWD)	$10.63M	N/A	N/A	N/A	N/A
Lisata Therapeutics, Inc. (LSTA)vs ›	$10.65M	N/A	2.09	2.09	2.09
CytoMed Therapeutics Limited (GDTC)vs ›	$10.51M	N/A	N/A	N/A	N/A
Satellos Bioscience Inc. (MSLE)vs ›	$10.44M	N/A	N/A	N/A	N/A
Cerenome, Inc. (CNSY)vs ›	$11.01M	N/A	N/A	N/A	N/A
Polyrizon Ltd. (PLRZ)vs ›	$10.34M	N/A	N/A	N/A	N/A
Senti Biosciences, Inc. (SNTI)vs ›	$10.33M	N/A	N/A	N/A	N/A
Caring Brands, Inc. (CABR)vs ›	$10.84M	N/A	N/A	N/A	N/A
Pluri Inc. (PLUR)vs ›	$11.11M	N/A	N/A	N/A	N/A
Kiora Pharmaceuticals, Inc. (KPRX)vs ›	$11.12M	N/A	2.43	2.43	2.43

P/E Comparison

Trailing P/E

N/A

Forward P/E

N/A

Forward P/E Calculation

View All Analyst Estimates

Forward P/E is calculated using analyst consensus EPS estimates for the current or next fiscal year.

Calculation:

Current Price

$6.60

÷

Forward EPS (Est.)

$-5.70

=

Forward P/E

N/A

Source: FMP Analyst Consensus Estimates. Forward EPS represents the average analyst estimate for the nearest fiscal year.

PE Ratio Formula & Definition

PE Ratio = Share Price / Diluted EPS (TTM)

The price-to-earnings ratio measures how much investors pay for each dollar of trailing earnings. A lower PE can indicate a cheaper valuation; a higher PE implies higher growth expectations.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

See the Lowest P/E Ratio Stocks ranking →

PE Ratio: N/A

LFWD PE Ratio Metrics

LFWD Competitors' PE Ratio

P/E Comparison

Forward P/E Calculation

PE Ratio Formula & Definition

Related Metrics